Japan-focused pharmaceutical information platformProfessional information & business enquiries
Prescription medicine

Dayvigo (Lemborexant)

デエビコ錠莱博雷生片

Japanese prescription-medicine information record for Dayvigo (Lemborexant), organized with source context and product-identification fields. This record is informational and does not provide prescribing or treatment guidance.

SKUTSU-RX-0129
Generic nameLemborexant
Therapeutic areaNeurology & Psychiatry

01 — PRODUCT OVERVIEW

Known product facts.

Generic name
Lemborexant
Dosage form
Tablet
Therapeutic area
Neurology & Psychiatry
Classification
Prescription medicine

02 — SOURCE & VERIFICATION

Keep the source visible.

Publication records keep source provenance and verification metadata. Secondary sources can support discovery, but production publication should be checked against official manufacturer or Japanese regulatory information.

SOURCE TYPESecondary discovery source
Open source ↗
LAST VERIFIEDNot verified for production
Catalogued record

03 — MEDICAL INFORMATION NOTICE

Information, not prescribing.

This page is for professional informational reference only. It does not constitute diagnosis, treatment, prescribing or dosing advice. Always refer to current approved product information, official safety communications and qualified healthcare professionals for medical decisions.